Logo image
A pharmacodynamic analysis of factors affecting recovery from anesthesia with propofol-remifentanil target controlled infusion
Journal article   Peer reviewed

A pharmacodynamic analysis of factors affecting recovery from anesthesia with propofol-remifentanil target controlled infusion

Bon-nyeo Koo, Jeong-rim Lee, Gyu-jeong Noh, Jae-hoon Lee, Young-ran Kang and Dong-woo Han
Acta pharmacologica Sinica, Vol.33(8), pp.1080-1084
08/01/2012
DOI: 10.1038/aps.2012.85
PMCID: PMC4011327
PMID: 22842732

View Online

Abstract

Aim: To examine individual patient's demographic parameters and clinical variables related to return of consciousness (ROC) and the pharmacodynamic relationship between propofol effect-site concentration (C-e) and ROC from propofol-remifentanil anesthesia. Methods: Ninety-four patients received propofol-remifentanil anesthesia using the effect-site target-controlled infusion (TCI) system. All clinical events were noted, and variables possibly related to propofol C-e at ROC were examined using linear correlation analyses. Pharmacodynamic modeling incorporating covariates was performed using NONMEM (Nonlinear Mixed Effects Modeling) VII software. Results: The C-e values of propofol at loss of consciousness (LOC) and ROC were 4.4 +/- 1.1 mu g/mL and 1.1 +/- 0.3 mu g/mL, respectively. Age was negatively correlated with propofol C-e at ROC (r=-0.48, P<0.01). Including age as a covariate in C-e50 (the effect-site concentration associated with 50% probability of return of consciousness) and. (the steepness of the concentration-versus-response relationship) significantly improved the performance of the basic model based on the likelihood ratio test, with a significant decrease in the minimum value of the objective function. The C-e50 in 25-, 50-, and 75-year-old patients was predicted to be 1.38, 1.06, and 0.74 mu g/mL, respectively. The lambda in 25-, 50-, and 75-year-old patients was predicted to be 12.23, 8.70, and 5.18, respectively. Conclusion: Age significantly affects the relationship between propofol C-e and ROC, and pharmacodynamic modeling including age could lead to better predictions of ROC during emergence from propofol-remifentanil anesthesia.
Chemistry Chemistry, Multidisciplinary Life Sciences & Biomedicine Pharmacology & Pharmacy Physical Sciences Science & Technology

Details

Metrics

Logo image